All Articles

Conversational AI firm LivePerson has added Nathan 'Tripp' Lane to its board, signaling a focus on operational efficiency and strategic realignment as the company adapts to a rapidly evolving market.

Itron’s acquisition of Locusview aims to streamline utility construction management, addressing aging infrastructure, grid modernization & the surge in renewable energy investments. The deal positions Itron for comprehensive solutions.

A New Jersey firm is challenging the traditional commission-based model in commercial real estate, securing a $30 million credit facility with favorable terms for its client and raising questions about the future of CRE brokerage.

Jill Evanko will transition to an advisory role as Chart Industries prepares to be acquired by Baker Hughes, a move signaling consolidation in the energy sector and a focus on clean energy solutions.

Automaker Kia Canada commits significant funds to Second Harvest, tackling food insecurity and reducing waste across the country. The partnership aims to deliver millions of meals and lessen environmental impact.

Five-year results from a Phase 2 trial show durable responses with REZLIDHIA in relapsed/refractory AML patients, even those previously treated with venetoclax. The data signals potential for expanded use and market growth.

Solid Biosciences’ licensing deal with Andelyn Biosciences signals a shift in gene therapy manufacturing – outsourcing critical components for broader access and accelerated development. A new business model emerges.

Biotech firm Angiex Inc. has raised $31 million to support Phase 1 trials of AGX101, a first-in-class antibody-drug conjugate designed to deliver cancer-killing drugs directly into tumor cell nuclei, offering a potentially more effective and targeted treatment.

WHO recognition of 'liraltagene autoleucel' marks a key milestone for Anixa Biosciences' innovative approach to treating recurrent ovarian cancer, offering a potential new hope for patients.

A new agreement with Sourcewell streamlines EV charging infrastructure procurement for government, education, and nonprofits, potentially unlocking widespread adoption and reducing emissions.

Silo Pharma partners with Allucent to advance a novel PTSD treatment while doubling down on a controversial cryptocurrency treasury strategy. Can this biopharmaceutical firm navigate both innovative science and volatile digital assets?

LG’s SKS brand is making a splash in the high-end appliance segment, leveraging cutting-edge AI technology and strategic partnerships to attract discerning home chefs. A look at their strategy and recent event.

Biotech firm Acumen Pharmaceuticals begins a long-term extension of its Phase 2 Alzheimer’s trial, focusing on a novel approach to combatting the disease by targeting soluble amyloid beta oligomers. Is this a turning point for Alzheimer's treatment?

The FDA has accepted a supplemental application for Arcutis Biotherapeutics’ ZORYVE cream, potentially offering the first-ever topical treatment for plaque psoriasis in children as young as 2 years old, addressing a significant gap in care.

Researchers have developed a new AI model that significantly improves melanoma detection by integrating dermoscopic images with crucial patient data – offering a potential leap forward in early diagnosis and accessibility.

A recent stock purchase by a Danske Bank executive is drawing attention, sparking debate over whether it reflects renewed optimism following years of compliance efforts and scrutiny over past misconduct.

GAC AION’s new i60 SUV aims to democratize extended-range electric driving with aggressive pricing and a robust charging network. Can it break through in China's crowded NEV market?

A new integration of emergency alert and mapping technologies aims to dramatically reduce response times, potentially saving lives by delivering crucial information to first responders in seconds, not minutes.

New SD6300 JBOD promises higher storage density, reduced data center footprint, and optimized CapEx/OpEx for AI, cloud, and hyperscale workloads.

Luxury brand Kate Spade is doubling down on celebrity partnerships with Ice Spice and Laufey, and leveraging Google’s Holiday 100 list to drive sales this season. A deeper look at the strategy and market trends.